U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Access & Pricing Strategy Team Lead - Immunology, Belgium

Corporate StrategyUpdated on Nov 14
Full-timeNo salary listed

About the Job

Requirements

  • A degree in life sciences, health economics, public health, pharmacy, business, or a related discipline.
  • Significant experience in payer strategy, market access, pricing, health economics, commercial, or related pharmaceutical functions.
  • Proven experience leading complex cross-functional initiatives and teams within global matrix organizations.
  • Strong understanding of payer evidence requirements, reimbursement processes, pricing strategy, and access planning.
  • Demonstrated people leadership experience, including coaching, capability development, and team management.
  • Experience leveraging analytics, digital tools, and artificial intelligence-enabled insights to support strategic planning.

Responsibilities

  • Lead and develop a team of Access & Pricing Strategy Leads, providing coaching, capability building, and strategic guidance.
  • Act as a strategic partner to Asset Payer Heads, developing global payer access and pricing strategy and global deliverables.
  • Lead payer strategy planning, evidence generation priorities, pricing strategy development, negotiation readiness activities, and key global deliverables.
  • Define and operationalize global access and pricing strategies for assigned indications across the asset lifecycle.
  • Shape strategic options, risk assessments, and trade-off discussions to support governance and investment decisions.
  • Ensure alignment between Patient Evidence and Patient Impact teams to drive integrated access strategies.
  • Bring payer insights and recommendations into key decision-making forums and leadership discussions.
  • Lead cross-functional collaboration across health economics and outcomes research, real-world evidence, policy, pricing, commercial, and regional access functions.
  • Champion the use of advanced analytics, artificial intelligence-enabled insights, and external market intelligence to strengthen payer planning.
  • Drive access and pricing excellence through governance, best practices, scalable processes, and continuous improvement initiatives.
  • Strengthen enterprise connectivity and create efficient ways of working that improve decision quality and organizational effectiveness.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs